Year: 2021

news_6

Asahi Kasei Company ZOLL Medical Corporation Donates $10M to The ZOLL Foundation to Support the Next Generation of Innovative Researchers in Resuscitation and Acute Critical Care

CHELMSFORD, Mass. & TOKYO--(BUSINESS WIRE)--#asahikasei--Asahi Kasei Corporation, a diversified Japanese multinational, today announced that its U.S. subsidiary ZOLL Medical Corporation...

news_6

Takeda to Acquire Maverick Therapeutics to Advance T-Cell Engager Therapies for Solid Tumors and Expand Novel Immuno-Oncology Portfolio

Acquisition expands Takeda’s immuno-oncology portfolio with two development candidates and Maverick’s conditionally active bispecific T-cell engagers COBRA™ platform, specifically designed...